Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with diabetes mellitus (DM).
- People who are over 40 years of age.
- People who have been diagnosed with peripheral neuropathy (nerve damage, usually causing pain, numbness, or tingling) where symptoms have lasted for more than 3 months.
- People who have reduced blood flow in the lower limbs, detected through a specific ultrasound scan called a duplex scan, showing changes in blood flow speed in a particular blood vessel (confirm with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have an implanted pacemaker, defibrillator, or nerve stimulator device.
- People who are pregnant.
- People who have a serious illness that would prevent them from following the study procedures.
- People who have a disability that would prevent them from attending and completing the required sessions.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ayman abdallah., phd, Beni-Suef University
Phone: +201151678506
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Neuropathy severity; blood perfusion.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.